Stock Comparison
BMY vs LLY
Bristol-Myers Squibb Company and Eli Lilly and Company side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$131.77B
$1.04T
P/E (TTM)
14.2
39.1
Forward P/E
9.4
32.1
Price/Sales
2.7
13.0
Price/Book
5.9
30.6
EV/EBITDA
9.9
26.0
Dividend Yield
2.91%
0.53%
Profitability
Net Margin
15.01%
33.53%
Operating Margin
25.67%
43.92%
Return on Equity
46.60%
102.30%
Return on Assets
10.70%
20.40%
Growth (YoY)
Revenue Growth
5.70%
47.70%
Earnings Growth
153.10%
26.20%
Price & Risk
Beta
0.2
0.5
52-Week High
$65.90
$1,235.65
52-Week Low
$41.66
$679.67
Analyst Target
$66.21
$1,297.31
Compare BMY and LLY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.